Association of serum omentin-1 concentrations with the presence of atrial fibrillation

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 4749-4754

  Tao, Sha ^a,b   Huang, Yu Qing ^b   Cai, An Ping ^b   Huang, Cheng ^b   Zhang, Ying ^b   Tang, Song Tao ^c   Yu, Xue Ju ^b   Zhou, Dan ^b   Tan, Ning ^a,b   Feng, Ying Qing ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Community Health Services Center of Liaobu Town ^*  (China)

Author keywords

Adipokines; Atrial fibrillation; Inflammation mediators; Obesity hypoventilation syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; UNCLASSIFIED DRUG; WARFARIN; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LEFT ATRIAL DIAMETER; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; HEART ATRIUM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADIPOKINES; ADULT; AGED; ATRIAL FIBRILLATION; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; DISEASE PROGRESSION; FEMALE; GPI-LINKED PROTEINS; HEART ATRIA; HUMANS; LECTINS; MALE; MIDDLE AGED;

EID: 85006152265     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.898202     Document Type: Article

References (23)

1. Sabashnikov A, Weymann A, Haldar S et al: Position of totally thoracoscopic surgical ablation in the treatment of atrialfibrillation: An alternative method of conduction testing. Med Sci Monit Basic Res, 2015; 21: 76–80
2. Yalcin MU, Gurses KM, Kocyigit D et al: Elevated M2-muscarinic and b1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation. Clin Res Cardiol, 2015; 104: 226–33
3. Schäffler A, Neumeier M, Herfarth H et al: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta, 2005; 1732: 96–102
4. Yang RZ, Lee MJ, Hu H et al: Identification of omentin as a novel depotspecific adipokine in human adipose tissue: Possible role inmodulating insulin action. Am J Physiol Endocrinol Metab, 2006; 290: E1253–61
5. de Souza Batista CM, Yang RZ, Lee MJ et al: Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 2007; 56: 1655–61
6. Kazama K, Okada M, Yamawaki H: A novel adipocytokine, omentin, inhibits monocrotaline-induced pulmonary arterial hypertension in rats. Biochem Biophys Res Commun, 2014; 452: 142–46
7. Yan P, Liu D, Long M et al: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 2011; 119: 257–63
8. Zhong X, Zhang HY, Tan H et al: Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin, 2011; 32: 873–78
9. Fuster V, Rydén LE, Asinger RW et al: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on PracticeGuidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol, 2001; 38: 1231–66
10. Choi BJ, Heo JH, Choi IS et al: Hypoadiponectinemia in patients with paroxysmal atrial fibrillation. Korean Circ J, 2012; 42: 668–73
11. Özcan KS, Güngör B, Altay S et al: Increased level of resistin predicts development of atrial fibrillation. J Cardiol, 2014; 63: 308–12
12. Demirtas S, Caliskan A, Karahan O et al: Neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury inpatients undergoing coronary artery bypass grafting. Exp Clin Cardiol, 2013; 18: 107–9
13. Yavuz C, Guclu O, Demirtas S et al: Can elevated prolidase activity predict the duration of ischemic exposure in different types of ischemia? Turk Gogus Kalp Dama, 2013; 21: 1000–4
14. Rosengren A, Hauptman PJ, Lappas G et al: Big men and atrial fibrillation: Effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J, 2009; 30: 1113–20
15. Tedrow UB, Conen D, Ridker PM et al: The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol, 2010; 55: 2319–27
16. Moreno-Navarrete JM, Catalán V, Ortega F et al: Circulating omentin concentration increases after weight loss. Nutr Metab (Lond), 2010; 7: 27
17. Saremi A, Asghari M, Ghorbani A: Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci, 2010; 28: 993–98
18. Kazama K, Okada M, Yamawaki H: A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism. Am J Physiol Heart Circ Physiol, 2014; 306: H1714–19
19. Aviles RJ, Martin DO, Apperson-Hansen C et al: Inflammation as a risk factor for atrial fibrillation. Circulation, 2003; 108: 3006–10
20. Yamawaki H, Kuramoto J, Kameshima S et al: Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun, 2011; 408: 339–43
21. Kazama K, Usui T, Okada M et al: Omentin plays an anti-inflammatory role through inhibition of TNF-a-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol, 2012; 686: 116–23
22. Pan HY, Guo L, Li Q: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract, 2010; 88: 29–33
23. Moreno-Navarrete JM, Ortega F, Castro A et al: Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring), 2011; 19: 1552–59